Mr Hamish Clouston

The Christie NHS Foundation Trust

Mr Clouston is a Colorectal and Peritoneal Surgeon in The Colorectal and Peritoneal Oncology Centre (CPOC) at The Christie NHS Foundation Trust. As a surgical oncologist in the CPOC he undertakes surgery for peritoneal pathology arising from tumours within the colon, rectum and appendix. This surgery includes Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. He also undertakes surgery for advanced colorectal malignancy including multivisceral rectal and colonic resections. As a core member of the anal cancer MDT he undertakes surgery for the early and recurrent anal cancers and the treatment of AIN. In his role as a core member of the neuroendocrine MDT he undertakes surgery for primary and metastatic neuroendocrine cancers.

dont miss

Surgical Management of Advanced Colonic and Rectal Malignancies.

The Colorectal and Peritoneal Oncology Centre (CPOC) at The Christie NHS Foundation Trust provides a tertiary service for patients with advanced colorectal cancer in the Greater Manchester(GM) conurbation and is the GM designated single provider for advanced pelvic malignancies requiring multi-visceral exenterative resections. The seminar will focus on indications for surgery for advanced colorectal malignancy, surgical considerations and outcomes of the surgery.

EVEN MORE SEMINARS

  • Dr Shanmugasundaram Ramkumar: Speaking at the Oncology Convention

    Dr Shanmugasundaram Ramkumar
    University Hospital Southampton NHS Foundation Trust

    Radiotherapy developments in management of recurrent rectal cancers

  • Dr Khurum Khan: Speaking at the Oncology Convention

    Dr Khurum Khan
    University College London Hospitals

    Translational research in GI Oncology- how to make progress?

  • Prof Ingunn Holen: Speaking at the Oncology Convention

    Prof Ingunn Holen
    Department of Oncology and Metabolism, University of Sheffield, UK

    Tumour cell dormancy and breast cancer relapse

  • Dr Abeer Shaaban: Speaking at the Oncology Convention

    Dr Abeer Shaaban
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

  • Dr Natalie Cook: Speaking at the Oncology Convention

    Dr Natalie Cook
    University of Manchester/Christie NHS Foundation Trust

    Molecular testing and novel therapies in prostate cancer